ObvioHealth is a virtual research organization (VRO) conducting decentralized clinical trials that deliver stronger therapeutic evidence.
ObvioHealth is on a mission to conduct innovative and efficient trials that deliver stronger evidence for better health outcomes. We use technology to develop more precise and accessible measurement tools to capture more robust and accurate data—so life-improving innovations can get to market faster.
“I have been struck again and again by how important measurement is to improving the human condition."
Our success comes from the fusion of experienced clinical researchers and pioneering health technology.
ObvioHealth has been innovating clinical trials since 2017, when we launched one of the first-ever DCT platforms with a mobile app. Today, we are an industry leader, designing and running DCTs across the globe that generate more robust and accurate data.
We were purpose-built from the ground up to conduct decentralized clinical trials.
Expert in improving data quality and outcomes optimization for clinical trials. CEO of SPRIM Consultancy, with previous positions at Oracle, ERT, PHT and Biogen.
Recognized leader in pharmaceutical and CRO industries. Former President and Chief Executive Officer, North America of ICON Clinical Research.
Expert in the ePRO and eCOA, Lead eCOA solutions at ERT, with previous positions at PHT, Covance and Genelabs Diagnostics.
Expert in clinical information technology. Founder and executive consultant of eClinical Edge, formerly Global Vice-President of Partnerships at Medidata, with previous experience at Parexel International, IQVIA and Clinsoft.
Expert in scientific R&D innovation. Currently DigitalSolutions Consultant for Patient-Centric Remote Trials at Novartis, ObvioHealth, Glaxo SmithKline and Nestle.
Expert in eClincial technology trends. Formerly Chief Commercial Officer of Trial Grid and Vice President of Global Partner Business at Medidata.
Expert in drug development and commercialization strategy Former head of Strategy & Cell Therapy Unit for Oncology at Bayer, with previous experience at BMS, Onyx and Halozyme.
Everest PEAK Matrix®
Inc. 5000 (2x)
Reuters Finalist—Most Valuable Clinical Technology
CB News Shortlist
With a growing list of trials scheduled for launch in 2023, we are constantly innovating to find ways to further reduce patient burden while increasing data accuracy across a range of therapeutic areas.
Remote and hybrid positions, unlimited PTO, and company stock grants are just a few benefits of working for ObvioHealth.